Streetwise Reports' Article Archives — Current Month (29)
The latest news and a construction update on Pure Gold Mining's Canadian project are provided in an Echelon Wealth Partners report.
Azarga Uranium notes that the location of that mineralization supports the potential use of in situ recovery there.
Once it gets the green light, Torchlight Energy Resources intends to resume work on its two key projects.
North American oil and natural gas producer Ovintiv has restructured its crude oil derivatives in order to provide additional downside protection. In addition, the company is reducing its Q2/20 investments by $500 Million.
During the year, Adcore generated $15 million in revenue and $5.6 million in adjusted EBITDA.
Bucking the Trend: Uranium Market Gains Traction (04/07/2020)
Jordan Trimble of Skyharbour Resources lays out the reasons why the uranium bear market is coming to an end, and why his company is poised to take advantage of the upturn, in this conversation with Maurice Jackson of Proven and Probable.
Shares of PVH Corp. traded higher after the company reported that it had completed the sale of its Speedo North America business to the Pentland Group for $170 million in cash.
Common Sense 2.0 Part II (04/07/2020)
Outcrop Gold is wholly focused on its Colombia properties that have a long history of high-grade production.
Royalty Company Closes Two Concurrent Nevada Deals (04/06/2020)
Ely Gold Royalties completes a claims acquisition and a related consolidated land sale.
Southern Silver Exploration Corp. has agreed to purchase the El Sol mineral claim in Durango for US$300,000.
Rigged Market Socialism (04/06/2020)
With his portfolio "solidly anchored" in silver and gold, sector expert Michael Ballanger opines on how bankers and politicians can manipulate markets.
Shares of Immunomedics opened 117% higher after the company reported that it has stopped its Phase 3 ASCENT study of sacituzumab govitecan after recording "compelling evidence of efficacy" in heavily pretreated patients with metastatic triple-negative breast cancer.
Common Sense 2.0 Part I (04/06/2020)
Animal Feed Supplement Maker Expands Asia Footprint (04/04/2020)
Avivagen receives new orders from two eastern countries for its product.
Shares of Fate Therapeutics traded higher after the firm reported it has treated the first patient in a first-in-human trial of FT596 for patients with B-cell malignancies and chronic lymphocytic leukemia.
In conversation with Maurice Jackson of Proven and Probable, the CEO of Millrock Resources describes the company's latest news.
In light of COVID-19, Liberty Gold states that it is proceeding safely, requiring workers to take certain health precautions.
Virus Impact Unknown for Many Companies (04/02/2020)
Money manager Adrian Day reviews non-resource stocks from around the world, noting that although he is cautious on global markets right now, with a few exceptions, some of the stocks on his list will be rated good buys on any dips.
Aben Resources advised that it has implemented company-wide safety measures to protect the health of all of its stakeholders including office staff, field crews, contractors and local communities during the coronavirus pandemic.
This project, along with two other new projects, increases the company's order backlog by 65%.
Shares of WPX Energy traded 25% higher after President Trump tweeted that he expected a deal between Russia and Saudi Arabia to scale back oil production.
Three COVID-19 Patients Treated with PLX Cells (04/01/2020)
Two programs, one new and the other ongoing, involving Pluristem Therapeutics' regenerative products are reviewed in a Dawson James report.
CloudMD reported that it has launched its telemedicine app in Ontario as coronavirus concerns have greatly increased the need for digital healthcare.
Gold Terra Resource reports more drill results from its winter 2020 program.
Recruiter.com identifies the sectors with the greatest hiring demand due to the newly changed job market.
VSBLTY Groupe Technologies is providing the software that powers the monitoring system.
Chembio Diagnostics shares traded higher and set a new 52-week high price after the company reported that it has launched a DPP® COVID-19 serological point-of-care test which can deliver IgM/IgG antibody results in 15 minutes using a simple finger stick.
Technical analyst Clive Maund discusses what he sees ahead for the markets.
|"PVG's Brucejack continues to deliver strong free cash flows."|
|"The drills are still turning, and GBR has plenty of cash."|
|"LIO's current valuation is an attractive entry point for investment."|
|"MAG is a good vehicle for exposure to the lesser precious metal."|
|"We are initiating coverage on ELY with an Outperform rating."|